The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Vitamin Shoppe Inc

NYSE: VSI
Last

(U.S.) $35.37

Today's change-0.43 -1.20%
Updated September 1 11:01 AM EDT. Delayed by at least 15 minutes.
 

Vitamin Shoppe Inc

NYSE: VSI
Last

(U.S.) $35.37

Today's change-0.43 -1.20%
Updated September 1 11:01 AM EDT. Delayed by at least 15 minutes.

Vitamin Shoppe Inc down (U.S.)$0.43

Vitamin Shoppe Inc is lower today, dropping (U.S.)$0.43 or 1.20% to (U.S.)$35.37. Over the last five days, shares have gained 3.15%, but are down 27.19% for the last year to date. Shares have underperformed the S&P 500 by 6.22% during the last year.

Key company metrics

  • Open(U.S.) $35.07
  • Previous close(U.S.) $35.80
  • High(U.S.) $35.47
  • Low(U.S.) $35.06
  • Bid / Ask(U.S.) $35.36 / (U.S.) $35.42
  • YTD % change-27.19%
  • Volume47,646
  • Average volume (10-day)308,454
  • Average volume (1-month)334,503
  • Average volume (3-month)324,307
  • 52-week range(U.S.) $33.60 to (U.S.) $49.04
  • Beta0.82
  • Trailing P/E18.68×
  • P/E 1 year forward17.20×
  • Forward PEG2.58×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.89
Updated September 1 11:01 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.51%

Based on its net profit margin of 4.51%, Vitamin Shoppe Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.53%Sector:Cyclical Consumer Goods & ServicesIndustry:Retail - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 27, 201506/27/2015Mar 28, 201503/28/2015Dec 27, 201412/27/2014Sep 27, 201409/27/2014
Revenue322337290309
Total other revenue--------
Total revenue322337290309
Gross profit1081159597
Total cost of revenue214222195212
Total operating expense299306270288
Selling / general / administrative83847774
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)20-23
Other operating expenses, total--------
Operating income24312021
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax23312020
Income after tax14191212
Income tax, total91288
Net income14191212
Total adjustments to net income--------
Net income before extra. items14191212
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14191212
Inc. avail. to common incl. extra. items14191212
Diluted net income14191212
Dilution adjustment--0--0
Diluted weighted average shares29303031
Diluted EPS excluding extraordinary itemsvalue per share0.480.630.380.40
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.520.630.350.45